 |
 |
Date Announced: 20 Jul 2011
Fast and Effective Treatment for Toenail Fungus Now Available in US, Canada and Europe.
BRISBANE, Calif., July 20, 2011 (GLOBE NEWSWIRE) -- Cutera, Inc. (Nasdaq:CUTR - News), a leading worldwide provider of laser and light-based aesthetic systems for practitioners worldwide, today announced Health Canada approval for its GenesisPlus laser system. Featuring a powerful Nd: YAG laser, GenesisPlus provides a fast, effective and drug-free treatment for onychomycosis (nail fungus), warts and scars.
Kevin Connors, president and CEO of Cutera, said, "We are pleased that, with the recent Health Canada approval, GenesisPlus is now available to physicians throughout U.S., Canada and Europe. Current treatment options for nail fungus include prescription topicals and oral drugs, both of which have limited success rates. Some patients are not candidates for oral medications due to concerns of liver damage and other treatment limitations."
Known medically as onychomycosis, nail fungus often causes the toenails to become discolored, thickened and separated from the nail bed. The condition is common: approximately half of the population will have this condition during the course of their lives.
"I am very excited that this technology is now available in Canada," said Dr. Jaggi Rao, MD, FRCPC, Associate Clinical Professor for Medicine and Dermatology Residency Program Director, University of Alberta in Edmonton, Canada. "The GenesisPlus procedure is attractive to my patients who have been suffering with unsightly, deformed and discolored toenails. Patients experience no downtime and are extremely pleased."
GenesisPlus utilizes Cutera's patented microsecond technology and features a proprietary delivery system with a temperature sensor to improve practitioner and patient experience in certain procedures. In addition to treating onychomycosis, the system is approved for a variety of dermatology indications such as the treatment of wrinkles, vascular lesions, pigmented lesions, warts and accelerates scar remodeling, including surgical, hypertrophic and keloid scars.
Source: Cutera
E-mail: via web site
Web Site: www.cutera.com
| © 2024 SPIE Europe |
|
